Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR2 | O95136 | 1/20 | 0.42 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.41 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | PARP1 | P09874 | 2/20 | 0.39 |
| ▸ | F12 | P00748 | 2/20 | 0.39 |
| ▸ | BRD3 | Q15059 | 1/20 | 0.39 |
| ▸ | HPGDS | O60760 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.39 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.39 |
| ▸ | GRM5 | P41594 | 1/20 | 0.39 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30489496 | 0.81 | S1PR2 (0.46) | S1PR2BAZ2BTRPV1MEN1KMT2A | |
| SCHEMBL25634079 | 0.81 | CHRNA7 (0.42) | BAZ2BMEN1KMT2AKDM4EALOX15 | |
| SCHEMBL6475935 | 0.80 | PARP1 (0.43) | BAZ2BTRPV1PARP1F12MAPT | |
| SCHEMBL6482451 | 0.80 | PARP1 (0.44) | BAZ2BTRPV1PARP1F12MAPT | |
| SCHEMBL25425099 | 0.80 | PRMT5 (0.43) | MEN1KMT2ACDK9 | |
| SCHEMBL30489504 | 0.78 | S1PR2 (0.42) | S1PR2MEN1KMT2APARP1HPGDS | |
| SCHEMBL21114784 | 0.77 | CTSK (0.48) | BAZ2BTRPV1PARP1F12MAPT | |
| SCHEMBL21588265 | 0.77 | PARP1 (0.49) | TRPV1PARP1F12TNKS2PARP2 | |
| SCHEMBL29357232 | 0.77 | CTSK (0.48) | BAZ2BTRPV1PARP1F12MAPT | |
| SCHEMBL6481176 | 0.77 | PARP1 (0.45) | BAZ2BTRPV1PARP1F12MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250235463-A1 | PHENOXY AND BENZYLOXY SUBSTITUTED PSYCHOPLASTOGENS AND USES THEREOF | DELIX THERAPEUTICS, INC. | 2025-07-24 | — | — | US | disclosed |
| US-12295959-B2 | Phenoxy and benzyloxy substituted psychoplastogens and uses thereof | DELIX THERAPEUTICS, INC. (US) | 2025-05-13 | — | — | US | disclosed |
| EP-4448531-A1 | PHENOXY AND BENZYLOXY SUBSTITUTED PSYCHOPLASTOGENS AND USES THEREOF | Delix Therapeutics, Inc. (US) | 2024-10-23 | — | — | EP | disclosed |
| US-20240335454-A1 | PHENOXY AND BENZYLOXY SUBSTITUTED PSYCHOPLASTOGENS AND USES THEREOF | DELIX THERAPEUTICS, INC. | 2024-10-10 | — | — | US | disclosed |
| WO-2023114313-A1 | PHENOXY AND BENZYLOXY SUBSTITUTED PSYCHOPLASTOGENS AND USES THEREOF | DELIX THERAPEUTICS, INC. (US) | 2023-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240335454-A1 | PHENOXY AND BENZYLOXY SUBSTITUTED PSYCHOPLASTOGENS AND USES THEREOF | GAP43, BDNF, GRIN2A | S1PR2 1460/4885BAZ2B 618/4885TRPV1 2581/4885 |
| US-12295959-B2 | Phenoxy and benzyloxy substituted psychoplastogens and uses thereof | GAP43, BDNF, GRIN2A | S1PR2 1460/4885BAZ2B 618/4885TRPV1 2581/4885 |
| US-20250235463-A1 | PHENOXY AND BENZYLOXY SUBSTITUTED PSYCHOPLASTOGENS AND USES THEREOF | GAP43, BDNF, GRIN2A | S1PR2 1460/4885BAZ2B 618/4885TRPV1 2581/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.